Effects of low-dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): Results from a real-world study

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia of unknown etiology. In several randomized clinical trials, and in the clinical practice, pirfenidone is used to effectively and safely treat IPF. However, sometimes it is difficult to use the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eung Gu, Lee, Tae-Hee, Hong, Yujin, Ryoo, Jiwon, Heo, Jung Won, Gil, Bo Mi, Kang, Hye Seon, Kwon, Soon Seog, Kim, Yong Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699661/
https://www.ncbi.nlm.nih.gov/pubmed/34941933
http://dx.doi.org/10.1371/journal.pone.0261684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699661/
https://www.ncbi.nlm.nih.gov/pubmed/34941933
http://dx.doi.org/10.1371/journal.pone.0261684

Ejemplares similares